HCWB ▼ -1.0% - HCW Biologics Inc. $HCWB - HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company’s Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer’s 41st Annual Meeting 06-NOV-2026 09:15 AM ET